ICI therapy in metastatic melanoma: autoantibodies identified as predictors for immune-related adverse events

Reactions Weekly 2026

View at publisher

DOI: 10.1007/s40278-026-92503-x

Cited by: 0

References: 1

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Cutaneous Melanoma Detection and Management Pharmacovigilance and Adverse Drug Reactions

References 1